FDA Approves Besremi for Essential Thrombocythemia: Evidence and India Status
What the FDA approval of ropeginterferon alfa-2b-njft for adults with essential thrombocythemia means—and what it does not establish in India.
New Drug & Drug Status
Verified regulator approvals and drug-status explainers with evidence and India availability caveats.
FDA Accelerated Approval of Sevabertinib: What Is Known and What Remains Uncertain
An evidence-focused explainer of the FDA accelerated approval of sevabertinib, including limitations and India regulatory status.
FDA Approves First Treatment for Alexander Disease: What the Evidence Shows
FDA has approved zilganersen as the first treatment for Alexander disease. Review the mechanism, trial evidence, safety signals and important limitations.